Navigation Links
IPL Quantum SR

ProductsIPL Quantum SR
Company Lumenis Inc.
Item IPL Quantum SR
Features Smart, simple-to-use operation. "No downtime," non-ablative treatment. Treats the full face, chest, neck and hands for a more youthful looking appearance. Two second repetition rate and large spot size. Provides quick procedure and high patient throughput. Pre-determined parameters and touch screen control for simplified operation with full parameter versatility, available for customized individual treatments. Contemporary, compact design with light, easy to hold treatment head and integrated contact cooling.
Description Intense pulse light technology in an upgradeable skin treatment system. IPL Quantum SR improves the appearance of photo-aged skin, removes age spots (sun-induced freckles), most benign brown pigments, and broken capillaries through a process called photorejuvenation. Innovative new applications of Intense Pulsed Light (IPLTM) treat facial vascular erythema and pigmentary sun damage in a single program.
Info Lumenis Inc.
Customer Service: 877-lumenis

Related medicine products :

1. IPL Quantum DL
2. Quantum
3. Quantum II
4. Quantum™ Maverick™ Balloon Catheter
5. QuantumPlex Streptavidin Beads
6. IPL (Intense Pulsed Light) Quantum DL
7. IPL (Intense Pulsed Light) Quantum SR
... provide you with everything you need ... evoked potential, or electro-oculogram. The ultra-bright ... to perform ERGs you never imagined ... negative response, and s-cone ERGs. Wireless ...
The PersonalLAB junior is an automated microplate analyzer capable of fully automating immunoenzymatic techniques using a microplate format, per the reagent manufacturer's instruction for use and spe...
... designed for high throughput microplate processing. The ... Stacker that handles up to 60 microplates ... model is equipped with a dual direct ... may be interfaced to increase flexibility as ...
... Processor is a precise, reliable and ... has been designed for OEM production. ... customised according to the method bottles ... able to process automatically the whole ...
Medicine Products:
(Date:10/13/2017)... , ... October 13, 2017 , ... The American Board ... become its next President and Chief Executive Officer, succeeding Dr. James C. Puffer upon ... beginning July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. Upon ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... ‘17, and Jennifer Huggins, PharmD ’17, along with clinical associate professor Janice ... of cardiovascular diseases during the 15th Annual Women’s Health Conference. The SIU ...
(Date:10/13/2017)... SAN LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... with Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for ... mean is the 90-day elimination period, when the family pays for care, is often ...
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th ... Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s CEO, ... The fun run is geared towards children of all ages; it is a non-competitive, ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Software Development, has been awarded a contract by the Center for Medicare and ... aims to accelerate the enterprise use of Agile methodologies in a consistent and ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... for their devotion to personalized service, SMP Pharmacy Solutions announces ... the South Florida Business Journal,s 50 Fastest-Growing Companies, and listed ... national specialty pharmacy has found its niche.  To that end, ... honored by SFBJ as the 2017 Power Leader in Health ... his award in October, Bardisa said of the three achievements, ...
(Date:9/25/2017)...   Montrium , an industry leader in ... IQPC Trial Master Files & Inspection Readiness Conference ... Clinical Services has selected eTMF Connect ... EastHORN, a leading European contract research organization (CRO), ... to enable greater collaboration with sponsors, improve compliance ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
Breaking Medicine Technology: